Abstract:The role of long intergenic noncoding RNA 346 (LINC00346) in inflammation is understudied. Overexpression or knockdown of LINC00346 respectively suppressed or enhanced LPS‐induced NF‐κB activation and cytokine expression in THP‐1 cells. LINC00346 acts as an miR‐25‐3p sponge, promoting PTEN expression. PTEN inhibits PI3K‐mediated AKT/NF‐κB pathway activation. Notably, LINC00346 and PTEN were simultaneously downregulated in breast cancer tissues. Experiments in MDA‐MB‐231 cells confirmed the functional relationship between LINC00346, miR‐25‐3p, and PTEN during LPS‐induced NF‐κB activation. These findings highlight LINC00346's impact on PTEN/PI3K balance and downstream AKT/NF‐κB pathway in inflammation. Background and Objective Long noncoding RNAs (lncRNAs) are crucial in regulating various physiological and pathological processes, including immune responses. LINC01686 is a lncRNA with previously uncharacterized functions in immune regulation. This study aims to investigate the function of LINC01686 in lipopolysaccharide (LPS)‐induced inflammatory responses in the human monocytic leukemia cell line THP‐1 and its potential regulatory mechanisms involving miR‐18a‐5p and the anti‐inflammatory protein A20. Method THP‐1 cells were stimulated with LPS to induce inflammatory responses, followed by analysis of LINC01686 expression levels. The role of LINC01686 in regulating the expression of interleukin (IL)‐6, IL‐8, A20, and signal transducer and activator of transcription 1 (STAT1) was examined using small interfering RNA‐mediated knockdown. Additionally, the involvement of miR‐18a‐5p in LINC01686‐mediated regulatory pathways was assessed by transfection with decoy RNAs mimicking the miR‐18a‐5p binding sites of LINC01686 or A20 messenger RNA. Results LINC01686 expression was upregulated in THP‐1 cells following LPS stimulation. Suppression of LINC01686 enhanced LPS‐induced expression of IL‐6 and IL‐8, mediated through increased production of reactive oxygen species. Moreover, LINC01686 knockdown upregulated the expression and activation of IκB‐ζ, STAT1, and downregulated A20 expression. Transfection with decoy RNAs reversed the effects of LINC01686 suppression on A20, STAT1, IL‐6, and IL‐8 expression, highlighting the role of LINC01686 in sponging miR‐18a‐5p and regulating A20 expression. Conclusion This study provides the first evidence that LINC01686 plays a critical role in modulating LPS‐induced inflammatory responses in THP‐1 cells by sponging miR‐18a‐5p, thereby regulating the expression and activation of A20 and STAT1. These findings shed light on the complex regulatory mechanisms involving lncRNAs in immune responses and offer potential therapeutic targets for inflammatory diseases.

TAX1BP1/A20 inhibited TLR2-NF-κB activation to induce tolerant expression of IL-6 in endothelial cells

Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflammation via the NF-κB pathway.

Endothelial Foxp1 Suppresses Atherosclerosis Via Modulation of Nlrp3 Inflammasome Activation.

A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48- and K63-linked polyubiquitination of effectors MyD88 and TBK1

A20 Inhibits Lipopolysaccharide-Induced Inflammation in Enterocytes.

Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma

New insights into the suppression of inflammation and lipid accumulation by JAZF1

An Interaction Between Brg1 And Histone Modifying Enzymes Mediates Lipopolysaccharide-Induced Proinflammatory Cytokines In Vascular Endothelial Cells

Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-κB pathway and SUMOylation

Abstract 029: Interleukin-35 Suppresses Endothelial Activation by Inhibiting Mitochondrial Reactive Oxygen Species Mediated Site-specific Acetylation of Histone 3 Lysine 14

MicroRNA-146a-5p alleviates lipopolysaccharide-induced NLRP3 inflammasome injury and pro-inflammatory cytokine production via the regulation of TRAF6 and IRAK1 in human umbilical vein endothelial cells (HUVECs)

T-Box20 Suppresses Oxidized Low-Density Lipoprotein-induced Human Vascular Endothelial Cell Injury by Upregulation of PPAR-γ

Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells.

Abstract 211: IL-35 Suppresses Endothelial Cell Activation by Inhibiting Histone H3K14 Acetylation and AP-1

Abstract 309: TLR4 Gene Silencing Attenuates Atherosclerosis Progression Via Inhibition of PI3-kinase/Akt/NF-κB Signaling Pathway in Apolipoprotein E Knockout Mice

LINC01686 affects LPS‐induced cytokine expression via the miR‐18a‐5p/A20/STAT1 axis in THP‐1 cells

Endothelial Lipase is Upregulated by Interleukin-6 Partly Via the P38 MAPK and P65 NF-κB Signaling Pathways.

Methyltransferase Dot1l Preferentially Promotes Innate IL-6 and IFN-β Production by Mediating H3K79me2/3 Methylation in Macrophages

Ataxin-10 Inhibits TNF-α-Induced Endothelial Inflammation Via Suppressing Interferon Regulatory Factor-1.

Histone Methyltransferase Ash1l Suppresses Interleukin-6 Production and Inflammatory Autoimmune Diseases by Inducing the Ubiquitin-Editing Enzyme A20

Thioredoxin-interacting Protein Promotes Activation and Inflammation of Monocytes with DNA Demethylation in Coronary Artery Disease